These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 10027654)

  • 21. A double blind parallel group placebo controlled comparison of sedative and mnesic effects of etifoxine and lorazepam in healthy subjects [corrected].
    Micallef J; Soubrouillard C; Guet F; Le Guern ME; Alquier C; Bruguerolle B; Blin O
    Fundam Clin Pharmacol; 2001 Jun; 15(3):209-16. PubMed ID: 11468032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.
    Curran HV; Schifano F; Lader M
    Psychopharmacology (Berl); 1991; 103(1):83-90. PubMed ID: 2006245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial.
    Wingen M; Bothmer J; Langer S; Ramaekers JG
    J Clin Psychiatry; 2005 Apr; 66(4):436-43. PubMed ID: 15816785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability.
    Preston KL; Wolf B; Guarino JJ; Griffiths RR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):707-20. PubMed ID: 1501118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam.
    Hege SG; Ellinwood EH; Wilson WH; Helligers CA; Graham SM
    Psychopharmacology (Berl); 1997 May; 131(2):101-7. PubMed ID: 9201796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers.
    Zacny JP
    Psychopharmacology (Berl); 2003 Jan; 165(2):146-56. PubMed ID: 12404072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers.
    Hallam KT; Olver JS; McGrath C; Norman TR
    Hum Psychopharmacol; 2003 Dec; 18(8):619-25. PubMed ID: 14696021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
    Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
    Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man.
    Aranko K; Mattila MJ; Seppälä T
    Br J Clin Pharmacol; 1983 May; 15(5):545-52. PubMed ID: 6134543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests.
    Vermeeren A; Jackson JL; Muntjewerff ND; Quint PJ; Harrison EM; O'Hanlon JF
    Psychopharmacology (Berl); 1995 Mar; 118(1):1-9. PubMed ID: 7597114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sedation and memory: studies with a histamine H-1 receptor antagonist.
    Turner C; Handford AD; Nicholson AN
    J Psychopharmacol; 2006 Jul; 20(4):506-17. PubMed ID: 16401664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of low doses of lorazepam on psychometric tests in healthy volunteers.
    Bourin M; Couëtoux du Tertre A; Colombel MC; Auget JL
    Int Clin Psychopharmacol; 1994; 9(2):83-8. PubMed ID: 8056998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam.
    Busto UE; Kaplan HL; Wright CE; Gomez-Mancilla B; Zawertailo L; Greenblatt DJ; Sellers EM
    J Clin Psychopharmacol; 2000 Dec; 20(6):628-35. PubMed ID: 11106134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moxonidine and cognitive function: interactions with moclobemide and lorazepam.
    Wesnes K; Simpson PM; Jansson B; Grahnén A; Weimann HJ; Küppers H
    Eur J Clin Pharmacol; 1997; 52(5):351-8. PubMed ID: 9272403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.
    de Haas SL; Franson KL; Schmitt JA; Cohen AF; Fau JB; Dubruc C; van Gerven JM
    J Psychopharmacol; 2009 Aug; 23(6):625-32. PubMed ID: 18635696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers.
    Hindmarch I; Trick L; Ridout F
    Psychopharmacology (Berl); 2005 Dec; 183(2):133-43. PubMed ID: 16205916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lormetazepam effects on daytime vigilance, psychomotor performance and simulated driving in young adult healthy volunteers.
    Iudice A; Bonanni E; Maestri M; Nucciarone B; Brotini S; Manca L; Iudice G; Murri L
    Int J Clin Pharmacol Ther; 2002 Jul; 40(7):304-9. PubMed ID: 12139207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers.
    Hindmarch ; Shamsi Z
    Curr Med Res Opin; 2001; 17(4):273-81. PubMed ID: 11922401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function.
    Wilkinson CJ
    J Clin Psychiatry; 1995 Jul; 56(7):309-18. PubMed ID: 7615484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing the subjective, psychomotor, and physiological effects of oral propoxyphene in non-drug-abusing volunteers.
    Zacny JP; Goldman RE
    Drug Alcohol Depend; 2004 Feb; 73(2):133-40. PubMed ID: 14725952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.